genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Artificial Intelligence
Putting COVID-19 on the ‘Map’
GEN Edge
Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths
GEN Edge
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
GEN Edge
Top 15 Best-Selling Drugs of 2019
News
News
Trivalent CAR T Cells a Triple Threat to Leukemia Cells
News
Role of Gene Mutations in Kidney Disease Described in New Study
News
Hereditary Gene Defect Found to be Most Common Cause of Childhood…
Neuroscience
Autism Gender Bias Explained in Some Cases by Single Amino Acid…
Coronavirus
COVID-19 Vaccine Progress in Pittsburgh
Insights
All
Trends for 2020
Commentary
Understanding Glycans in COVID-19 Drug Design
Coronavirus
NYC Scientists Swab the Subway in Search of SARS-CoV-2
Artificial Intelligence
Artificial Intelligence Is Helping Biotech Get Real
April 2020 Vol. 40 No.4
Cell-Based Immunotherapies Do Battle With Solid Tumors
A-Lists
Gilead Sciences
Catching Up to Coronavirus: Top 60 Treatments in Development
GEN Edge
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Trivalent CAR T Cells a Triple Threat to Leukemia Cells
News
Role of Gene Mutations in Kidney Disease Described in New Study
News
Hereditary Gene Defect Found to be Most Common Cause of Childhood…
Neuroscience
Autism Gender Bias Explained in Some Cases by Single Amino Acid…
Magazine
March 2020 Vol. 40 No. 3
Expanding the CRISPR Toolbox
Commentary
Strategies for Optimizing CRISPR-Cas9 Delivery into Hard-to-Transfect Cells
March 2020 Vol. 40 No. 3
RNA Silencing Finds Its Therapeutic Voice
March 2020 Vol. 40 No. 3
Genomic Medicine Identifies Reconcilable Differences
Commentary
Hasten Genomic Medicine’s Rise with Advanced Data Management
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Feel the Flow: Immune Cell Signaling Cascades Reveal Phenotype and Function
April 2020 Vol. 40 No.4
A New Lease on Life for shRNA
April 2020 Vol. 40 No.4
To Improve Protein Aggregation Assessments, Combine PCT and MMS
April 2020 Vol. 40 No.4
Protein Labeling Kit
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Blood Disorders
Blood Disorders
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Blood Disorders
Blood Clotting Disorder’s Origins Revealed
Blood Disorders
Gilead to Acquire Forty Seven for $4.9B, Expanding Immuno-Oncology Pipeline
Blood Disorders
Global Blood Therapeutics CEO Defends Price of Sickle-Cell Drug Oxbryta
Blood Disorders
Gene Therapy Trial Helps Six X-CGD Patients
Blood Disorders
Sangamo CEO Looks Long-Term toward In Vivo Genome Editing, Regulation
Blood Disorders
Celgene, Acceleron Win FDA OK for Drug to Treat Anemia in...
Blood Disorders
NIH, Gates Foundation Commit $200M to HIV, Sickle Cell Gene Therapies
Blood Disorders
Gene Therapy Vehicle for Sickle-Cell Disease Shifts Forward
Blood Disorders
Senescent Cells Promote Blood Clotting
Blood Disorders
CRISPR Editing of Stem Cell Subset Reactivates Fetal Hemoglobin for Treating...
Blood Disorders
Chimerix Licenses Cantex’s CX-01 for AML after Promising Phase II Results
Blood Disorders
Sepsis Study Reveals Four Subtypes, Suggests Why Some Trials Miss Mark
Blood Disorders
Takeda Sells Two Drugs for $5.7B+, Licenses a Third, in Deals...
Blood Disorders
Sepsis Prediction May be Possible with New Computer Model
Blood Disorders
After 2 Patient Deaths, FDA Imposes Partial Clinical Hold on Trial...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
